Atlas Venture Fund VIII L.P. 13D/13G Filings for Bicycle Therapeutics plc (BCYC)

Atlas Venture Fund VIII L.P. 13D and 13G filings for Bicycle Therapeutics plc:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-02
1:00 pm
Sale
2020-12-3113GBicycle Therapeutics plc
BCYC
Atlas Venture Fund VIII L.P.612,696
2.880%
-750,000decrease
(-55.04%)
Filing